Lundbeck
Lundbeck is a global pharmaceutical company specialized in brain diseases.
Launch date
Employees
Market cap
CAD8.9b
Enterprise valuation
CAD8.0b (Public information from Sep 2024)
Share price
DKK39.45 LUN.CO
Copenhagen Capital Region of Denmark (HQ)
Corporate Venture Fund: Lundbeckfonden Ventures
No columns specified